Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Dorte Gillstrom"'
Autor:
Victor Vishwanath Iyer, Morton Coleman, Paw Jensen, Mikael Eriksson, Dorte Gillstrom, Dominick Lamonica, Myron S. Czuczman, Per Boye Hansen, Annika Loft, Marko Seppänen, Helle W. Hendel, Martin Hutchings, Karen Juul Mylam, Karin Hjorthaug, Sirpa Leppä, Peter de Nully Brown, Lars Møller Pedersen, Harald Holte, Lale Kostakoglu, Sirkku Jyrkkiö, Anne Lerberg Nielsen, Louis F. Diehl
Publikováno v:
Juul Mylam, K, Kostakoglu, L, Hutchings, M, Coleman, M, Lamonica, D, Czuczman, M S, Diehl, L F, Nielsen, A L, Jensen, P, Loft, A, Hendel, H W, Iyer, V, Leppa, S, Jyrkkio, S, Holte, H, Eriksson, M, Gillstrøm, D, Hansen, P B, Seppanen, M, Hjorthaug, K, Brown, P N & Pedersen, L M 2015, ' 18 F-fluorodeoxyglucose-positron emission tomography/computed tomography after one cycle of chemotherapy in patients with diffuse large B-cell lymphoma : results of a Nordic/US intergroup study ', Leukemia and Lymphoma, vol. 56, no. 7, pp. 2005-2012 . https://doi.org/10.3109/10428194.2014.975800
Mylam, K J, Kostakoglu, L, Hutchings, M, Coleman, M, Lamonica, D, Czuczman, M S, Diehl, L F, Nielsen, A L, Jensen, P, Loft, A, Hendel, H W, Iyer, V, Leppä, S, Jyrkkiö, S, Holte, H, Eriksson, M, Gillstrøm, D, Hansen, P B, Seppänen, M, Hjorthaug, K, Brown, P D N & Pedersen, L M 2015, ' 18 F-fluorodeoxyglucose-positron emission tomography/computed tomography after one cycle of chemotherapy in patients with diffuse large B-cell lymphoma : results of a Nordic/US intergroup study ', Leukemia and Lymphoma, vol. 56, no. 7, pp. 2005-2012 . https://doi.org/10.3109/10428194.2014.975800
Mylam, K J, Kostakoglu, L, Hutchings, M, Coleman, M, Lamonica, D, Czuczman, M S, Diehl, L F, Nielsen, A L, Jensen, P, Loft, A, Hendel, H W, Iyer, V, Leppä, S, Jyrkkiö, S, Holte, H, Eriksson, M, Gillstrøm, D, Hansen, P B, Seppänen, M, Hjorthaug, K, Brown, P D N & Pedersen, L M 2015, ' 18 F-fluorodeoxyglucose-positron emission tomography/computed tomography after one cycle of chemotherapy in patients with diffuse large B-cell lymphoma : results of a Nordic/US intergroup study ', Leukemia and Lymphoma, vol. 56, no. 7, pp. 2005-2012 . https://doi.org/10.3109/10428194.2014.975800
We evaluated the predictive value of interim positon emission tomography (I-PET) after one course of chemoimmunotherapy in patients with newly diagnosed diffuse large B-cell lymphoma (DLBCL). One hundred and twelve patients with DLBCL were enrolled.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::51acd2499788d3da40225563e2624f94
https://portal.findresearcher.sdu.dk/da/publications/7aa37224-49f3-4433-83e3-b9702be374b1
https://portal.findresearcher.sdu.dk/da/publications/7aa37224-49f3-4433-83e3-b9702be374b1
Autor:
Amore, Francesco Annibale D., Judit Meszaros Jørgensen, Ida Blok Sillesen, Erik Segel, Hans Herluf Nørregaard Bentzen, Thorsgaard, M., Elisa Pulcynski, Bjarne Pedersen, Dorte Gillstrom, Michael Roost Clausen, Peter Kamper, Trine Silkjær, Lars Christian Gormsen, Sirpa Leppä, Helle Toldbod
Publikováno v:
D'Amore, F A, Jørgensen, J M, Sillesen, I B, Segel, E, Bentzen, H H N, Thorsgaard, M, Pulcynski, E, Pedersen, B, Gillstrom, D, Clausen, M R, Kamper, P, Silkjær, T, Gormsen, L C, Leppä, S & Toldbod, H 2014, ' Preliminary clinical experience on the efficacy and feasibility of a new combination regimen consisting of pixantrone, etoposide and bendamustine with or without the addition of rituximab in patients with relapsed/refractory aggressive non-hodgkin lymphomas ', Blood, vol. 124, no. 21 .
Aarhus University
Aarhus University
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::1c9847865ae84c66f7728f6fec0ee953
https://pure.au.dk/portal/da/publications/preliminary-clinical-experience-on-the-efficacy-and-feasibility-of-a-new-combination-regimen-consisting-of-pixantrone-etoposide-and-bendamustine-with-or-without-the-addition-of-rituximab-in-patients-with-relapsedrefractory-aggressive-nonhodgkin-lymphomas(e1902c8e-8b7e-4e83-9d3d-962a1dbdf0b7).html
https://pure.au.dk/portal/da/publications/preliminary-clinical-experience-on-the-efficacy-and-feasibility-of-a-new-combination-regimen-consisting-of-pixantrone-etoposide-and-bendamustine-with-or-without-the-addition-of-rituximab-in-patients-with-relapsedrefractory-aggressive-nonhodgkin-lymphomas(e1902c8e-8b7e-4e83-9d3d-962a1dbdf0b7).html
Autor:
Marie Nordström, Jan Delabie, Marja-Liisa Karjalainen-Lindsberg, Per Boye Hansen, Arne Kolstad, Elisabeth Ralfkiaer, Unn-Merete Fagerli, Mats Ehinger, Trond Velde Bogsrud, Riikka Räty, Hans Bentzen, Christer Sundström, Grete F. Lauritzsen, Herman Nilsson-Ehle, Dorte Gillstrom, Christian H. Geisler, Niels Smedegaard Andersen, Annika Loft, Mats Jerkeman, Erkki Elonen, Lone Bredo Pedersen, Anna Laurell, Peter Meyer, Anne Kristine Lehmann
Publikováno v:
Blood. 114:932-932
Abstract 932 The Nordic Lymphoma Group has since 1996 conducted three consecutive phase II trials for front-line treatment of MCL patients ≤ 65 years of age. The first protocol (MCL1) 1996-2000 introduced high-dose chemotherapy with autologous stem
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1cfa03bb20db5f86eca32912d28d4c73
https://doi.org/10.1182/blood.v114.22.932.932
https://doi.org/10.1182/blood.v114.22.932.932
